Standardization has proven one of the most bedeviling issues for clinicians attempting to compare lab data generated at different locations using varying technology.
On December 5, AACC and the AACC Industry Division will offer a program session on ongoing efforts to eliminate variability in lab data results. Laboratory Test Standardization Efforts: An Update will explore the role taken by nonprofits and government agencies as they work to standardize laboratory measurands. The session is geared toward in vitro diagnostics (IVD) professionals and clinical laboratory leaders who wish to engage with the topics at hand.
Cas Weykamp, clinical chemist and director of the MCA Laboratory for the Queen Beatrix Hospital in the Netherlands and Hubert Vesper, chief of the Protein Biomarkers Laboratory, Division of Laboratory Sciences for the Centers for Disease Control and Prevention’s National Center for Environmental Health, will speak. Topics to be addressed include the stakes associated with standardization; factors undermining measurand integrity and the importance of the traceability chain; the role and approach of standards-setting groups as they partner with IVD manufacturers and clinical laboratories; projects currently in development; and updates on ISO 17511, IFCC standardization efforts, the European Community’s IVD Directive, and AACC’s Harmonization Initiative.
The event will take place on December 5, 1 to 2 pm Eastern time and is AACC-approved for 1 Category 1 ACCENT Credit hour. You can register on the AACC website.
